US silicone breast implants panel: has FDA regulated fairly?
This article was originally published in Clinica
Executive Summary
The Washington Legal Foundation accused the FDA yesterday of violating clearly-established rules governing administrative procedures in its handling of pre-market applications for silicone gel breast implants, writes Karen Riley at the panel meeting.